Manufacturer
APOTEX INC
Contents
Perphenazine
Indication
Severe Nausea and Vomiting, Mania, Psychoses and Schizophrenia.
Instruction
Should be taken with food.
Drug interaction
Increased plasma concentration when given w/ ritonavir or TCAs. Inhibit metabolism of perphenazine when taken w/ paroxetine. Absorption may be reduced w/ kaolin or antacids. Reduced effects w/ memantine. Additive hypotensive effects w/ antihypertensive agents. Risk of sedation or toxicity w/ CNS
Malaysia
